By Editor , 29 September 2026
Thyme Companies Names Flatiron Health Ex-CEO Starrett to Lead New Ventures

Nashville, Tenn. – – September 29, 2026 -- Thyme Companies has appointed Carolyn Starrett as executive vice president of new ventures, tasking her with identifying and scaling new businesses beyond its existing Thyme Care platform. Starrett reports directly to Executive Chairman Robin Shah, marking her second collaboration with him after their tenure together at Flatiron Health.

By Editor , 29 September 2026

Atlanta – September 29, 2026 -- The Jack & Jill Late Stage Cancer Foundation (JAJF) has completed 20 years of funding fully-paid family trips for parents with terminal cancer diagnoses, a model now formally prescribed by oncologists across the United States as part of patient treatment protocols.

By Editor , 29 September 2026

Campbell, Calif. – September 29, 2026 -- Vivalink, a digital healthcare solutions provider, published survey data showing 79% of more than 150 U.S. adults with cardiac conditions would participate in a home-based cardiac rehabilitation program if recommended by a provider.

Patients favor hybrid or home-based rehab over clinic visits

When given a choice, 68% of respondents said they would prefer a primarily home-based or hybrid rehabilitation approach over traditional in-clinic programs.

By Editor , 29 September 2026
Deloitte: Proactive Care Could Unlock $527B in U.S. Women's Health Spending

New York – – September 29, 2026 -- Deloitte analysis projects that shifting U.S. healthcare from reactive treatment to proactive, life-stage-aware care could generate $527 billion in additional potential spending on women's health by 2030 compared with a baseline trajectory.

By Editor , 29 September 2026

Linköping – – September 29, 2026 -- Swedish medical imaging IT firm Sectra (STO: SECT B) has signed a partner agreement with S&S Partners to enter Brazil, Latin America's largest healthcare market, with an initial focus on its cloud-based enterprise imaging platform Sectra One Cloud.

By Editor , 29 September 2026
Congress Passes ACT for ALS Reauthorization, Extends Programs to 2031

Los Angeles – – September 29, 2026 -- Congress has passed the Accelerating Access to Critical Therapies (ACT) for ALS Reauthorization Act of 2026 (H.R. 8205), sending the bipartisan bill to the President's desk just two days before the underlying program was set to expire on September 30, 2026.

By Editor , 29 September 2026
AMP, Fuse Oncology Launch FuseRx Radiation Workflow Pilot in Syracuse

Syracuse – – September 28, 2026 -- Fuse Oncology and Associated Medical Professionals of NY (AMP), an affiliate of U.S. Urology Partners, a General Atlantic company, have launched a proof of concept for FuseRx, a clinical workflow platform for radiation oncology, at AMP's Center of Advanced Radiation Excellence in Syracuse.